Rituximab and Abatacept for Prevention or Reversal of Type 1 Diabetes
Type 1 Diabetes Mellitus Diabetes Mellitus Diabetes Mellitus, Type 1 Rituximab Abatacept Rituximab followed by Abatacept
Lead Scientist at UCSF
- Stephen Gitelman, MD
I am involved in a variety of different translational and clinical research projects, most related to diabetes. A number of the on-going studies are attempts to alter the course of autoimmune-mediated type 1 diabetes, often via immunomodulation, in order to preserve endogenous beta cell function. Some of the recent and on-going projects are described below.